MedCath Corp. expected to Report Q1 2010 Results on February 1, 2010. This event was calculated by Capital IQ (Created on November 13, 2009).

MedCath Corp. announced it has received licensure by the Arizona Department of Health Services and accreditation by The Joint Commission for its new 70-bed Hualapai Mountain Medical Center in Kingman, Ariz, which opened October 15th. The $70 million project is located in one of Arizona's fastest growing regions and a city whose population has doubled since 1990. Hualapai Mountain Medical Center will focus on providing high acuity services, and includes four operating rooms, one cath lab and a 22-bay emergency department. The hospital's services will include heart services, inpatient and outpatient surgery, medical services, intensive care and emergency services while employing state-of-the-art diagnostic imaging and laboratory services. The opening of the 189,000-square-foot facility marks the completion of MedCath's second significant construction project in 2009, following the 79-bed expansion of Louisiana Medical Center and Heart Hospital in May 2009.

MedCath Corp. reported unaudited consolidated earnings results for the fourth quarter and year ended September 30, 2009. For the quarter, the company reported net loss of $58,606,000 or $2.97 per diluted share on net revenue of $147,966,000 compared to net income of $469,000 or $0.02 per diluted share on net revenue of $145,511,000 for the same period a year ago. The company reported loss from operations of $62,794,000, loss from continuing operations before minority interest and income taxes of $62,221,000, loss from continuing operations before income taxes of $63,093,000 and loss from continuing operations of $61,900,000 or $3.14 per diluted share compared to income from operations of $4,362,000, income from continuing operations before minority interest and income taxes of $2,869,000, income from continuing operations before income taxes of $1,688,000 and income from continuing operations of $155,000 or $0.01 per diluted share for the same period a year ago. The company reported adjusted EBITDA of $9,538,000, adjusted diluted earnings per share of $0.04, cash flow from continuing operations of $10,722,000 and free cash flow of $3,738,000 compared to adjusted EBITDA of $11,530,000, adjusted diluted earnings per share of $0.02, cash flow from continuing operations of $9,894,000 and free cash flow of $1,872,000 for the same period a year ago. In addition to the non-cash goodwill impairment expense, the company's operating results reflect the items: $1.5 million, or $0.04, net per diluted share of the decrease in net revenue and Adjusted EBITDA related to anticipated settlement of third-party payor cost reports at two hospitals, and $0.9 million, or $0.03 per diluted share, in amortization expense related to the termination of a management contract at MedCath Partners Division. The company reported capital expenditure of $6,984,000 compared to capital expenditure of $8,022,000 for the same period a year ago. The company results include the impact of certain items that collectively had a $1.0 million negative impact to net revenue and adjusted EBITDA and a $0.02 impact to EPS from continuing operations. For the year, the company reported net loss of $50,282,000 or $2.55 per diluted share on net revenue of $602,042,000 compared to net income of $20,990,000 or $1.04 per diluted share on net revenue of $591,611,000 for the same period a year ago. The company reported loss from operations of $43,684,000, loss from continuing operations before minority interest and income taxes of $47,890,000, loss from continuing operations before income taxes of $57,218,000 and loss from continuing operations of $58,418,000 or $2.96 per diluted share compared to income from operations of $38,673,000, income from continuing operations before minority interest and income taxes of $34,293,000, income from continuing operations before income taxes of $21,747,000 and income from continuing operations of $12,373,000 or $1.04 per diluted share for the same period a year ago. The company reported adjusted EBITDA of $55,590,000, adjusted diluted earnings per share of $0.69, cash flow from continuing operations of $64,333,000 and free cash flow of $40,001,000 compared to adjusted EBITDA of $74,810,000, adjusted diluted earnings per share of $0.82, cash flow from continuing operations of $43,190,000 and free cash flow of $19,015,000 for the same period a year ago. The company reported capital expenditure of $24,332,000 compared to capital expenditure of $24,175,000 for the same period a year ago. The company reported impairment of goodwill of $60,174,000 for the fourth quarter ended September 30, 2009.